# Roche Molecular Systems, Inc. – FDA Inspection, Jan 27, 2011

Source: https://www.keypedia.com/records/fda_inspections/roche-molecular-systems-inc/f0046bd5-28cb-41ca-89c4-133837a6db6a
Source feed: FDA_Inspections

> FDA inspection 707713 of Roche Molecular Systems, Inc., January 27, 2011. Classification: Official Action Indicated (OAI). 14 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 707713
- Company Name: Roche Molecular Systems, Inc.
- Inspection Date: 2011-01-27
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1323692 - 2026-06-12
- [FDA Inspection 1224711 - 2023-12-08](https://www.keypedia.com/records/fda_inspections/roche-molecular-systems-inc/3562058a-f301-4312-9965-513037ddb191)
- FDA Inspection 1100926 - 2019-07-31
- FDA Inspection 1027092 - 2017-07-24
- [FDA Inspection 1020421 - 2017-07-19](https://www.keypedia.com/records/fda_inspections/roche-molecular-systems-inc/61eafec8-5360-49e5-a7c3-050777797698)

Company: https://www.keypedia.com/companies/roche-molecular-systems-inc/603d5520-1c54-4282-88f0-76549211cf07

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d